Showing results (601-610 of 611) with videos related to

Sort By:
Pageof 62
American Heart Journal|November 17, 2019
Diagnostic tools for early detection of cardiac dysfunction in childhood cancer survivors: Methodological aspects of the Dutch late effects after childhood cancer (LATER) cardiology studyJan M Leerink, E Lieke A M Feijen, Helena J H van der Pal, et al.
JACC. Cardiooncology|August 24, 2023
Extensive Cardiac Function Analyses Using Contemporary Echocardiography in Childhood Cancer Survivors: A DCCSS LATER StudyRemy Merkx, Jan M Leerink, E Lieke A M Feijen, et al.
The Lancet. Healthy Longevity|April 1, 2023
Frailty and sarcopenia within the earliest national Dutch childhood cancer survivor cohort (DCCSS-LATER): a cross-sectional studyJenneke E van Atteveld, Demi T C de Winter, Vincent G Pluimakers, et al.
Physical Review Letters|November 13, 2009
Investigation of the exclusive 3He(e,e' pn)1H reactionD G Middleton, J R M Annand, M Ases Antelo, et al.
European Journal of Cancer (Oxford, England : 1990)|September 9, 2020
Usefulness of current candidate genetic markers to identify childhood cancer patients at risk for platinum-induced ototoxicity: Results of the European PanCareLIFE cohort studyThorsten Langer, Eva Clemens, Linda Broer, et al.
Data in Brief|September 17, 2020
Association of candidate pharmacogenetic markers with platinum-induced ototoxicity: PanCareLIFE datasetThorsten Langer, Eva Clemens, Linda Broer, et al.
Fertility and Sterility|May 10, 2024
Interindividual variation in ovarian reserve after gonadotoxic treatment in female childhood cancer survivors - a genome-wide association study: results from PanCareLIFEM E Madeleine van der Perk, Linda Broer, Yutaka Yasui, et al.
Human Reproduction (Oxford, England)|February 14, 2021
Possible modification of BRSK1 on the risk of alkylating chemotherapy-related reduced ovarian functionAnne-Lotte L F van der Kooi, Marloes van Dijk, Linda Broer, et al.
Cancers|September 28, 2021
Effect of Genetic Variation in CYP450 on Gonadal Impairment in a European Cohort of Female Childhood Cancer Survivors, Based on a Candidate Gene Approach: Results from the PanCareLIFE StudyM E Madeleine van der Perk, Linda Broer, Yutaka Yasui, et al.
NPJ Precision Oncology|July 15, 2021
TCERG1L allelic variation is associated with cisplatin-induced hearing loss in childhood cancer, a PanCareLIFE studyA J M Meijer, F A Diepstraten, T Langer, et al.
Pageof 62